Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

Each library can contain institution-specific variables for up to 100 drugs. Each profile is developed to meet the infusion requirements of a particular type of patient or patient care area.

Hurricane Helene wrecked a factory in North Carolina that produced 60% of the fluids their sustenance is mixed from.

This technology provides a software filter to prevent key-stroke errors in programming infusion devices for delivery of i.v. drugs, as well as a new source of data with which to measure medication ...

CareFusion, a BD subsidiary, is conducting layoffs as well as moving some of its engineering and manufacturing jobs to other ...

A patient who received a new infusion therapy treatment for Parkinson’s disease showed progress after just two days, Sherwood Forest Hospitals said.

said Thursday the Food and Drug Administration has approved its vyalev as the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor ...

Tryptamine Therapeutics Ltd (ASX:TYP) has achieved a major milestone in assessment of its use of hallucinogen psilocin to ...

All products and services featured are independently chosen by editors. However, StyleCaster may receive a commission on ...